162 related articles for article (PubMed ID: 33294258)
1. ERRα promotes pancreatic cancer progression by enhancing the transcription of PAI1 and activating the MEK/ERK pathway.
Liu SL; Wu XS; Li FN; Yao WY; Wu ZY; Dong P; Wang XF; Gong W
Am J Cancer Res; 2020; 10(11):3622-3643. PubMed ID: 33294258
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
3. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
[TBL] [Abstract][Full Text] [Related]
4. Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression.
Mao X; Lei H; Yi T; Su P; Tang S; Tong Y; Dong B; Ruan G; Mustea A; Sehouli J; Sun P
J Exp Clin Cancer Res; 2022 Jan; 41(1):28. PubMed ID: 35045880
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.
Chen H; Pan J; Zhang L; Chen L; Qi H; Zhong M; Shi X; Du J; Li Q
Eur J Pharmacol; 2018 Apr; 825():133-142. PubMed ID: 29476880
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast Cancer.
Humphries BA; Buschhaus JM; Chen YC; Haley HR; Qyli T; Chiang B; Shen N; Rajendran S; Cutter A; Cheng YH; Chen YT; Cong J; Spinosa PC; Yoon E; Luker KE; Luker GD
Mol Cancer Res; 2019 May; 17(5):1142-1154. PubMed ID: 30718260
[TBL] [Abstract][Full Text] [Related]
7. ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells.
Zhou S; Xia H; Xu H; Tang Q; Nie Y; Gong QY; Bi F
J Exp Clin Cancer Res; 2018 Sep; 37(1):218. PubMed ID: 30185207
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/DUSP6/ERK axis.
Zhao H; Chen W; Zhu Y; Lou J
J Gastrointest Oncol; 2021 Aug; 12(4):1691-1703. PubMed ID: 34532120
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
10. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
Cell Signal; 2024 May; ():111227. PubMed ID: 38744388
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-related receptor α expression and function are associated with vascular endothelial growth factor in human cervical cancer.
Mori T; Sawada M; Kuroboshi H; Tatsumi H; Katsuyama M; Iwasaku K; Kitawaki J
Int J Gynecol Cancer; 2011 May; 21(4):609-15. PubMed ID: 21546870
[TBL] [Abstract][Full Text] [Related]
12. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
Han L; Liu B; Jiang L; Liu J; Han S
Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.
Yu G; Lin J; Liu C; Hou K; Liang M; Shi B
Sci Rep; 2017 Dec; 7(1):17176. PubMed ID: 29214989
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
Zhang Y; Li Y
Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
[TBL] [Abstract][Full Text] [Related]
17. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
[No Abstract] [Full Text] [Related]
18. PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer.
Peng YP; Zhu Y; Yin LD; Zhang JJ; Wei JS; Liu X; Liu XC; Gao WT; Jiang KR; Miao Y
J Exp Clin Cancer Res; 2017 Feb; 36(1):30. PubMed ID: 28193232
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling.
Auld KL; Berasi SP; Liu Y; Cain M; Zhang Y; Huard C; Fukayama S; Zhang J; Choe S; Zhong W; Bhat BM; Bhat RA; Brown EL; Martinez RV
J Mol Endocrinol; 2012 Apr; 48(2):177-91. PubMed ID: 22333182
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer.
Yoriki K; Mori T; Kokabu T; Matsushima H; Umemura S; Tarumi Y; Kitawaki J
Sci Rep; 2019 Apr; 9(1):6697. PubMed ID: 31040369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
